Is SUVmax of


Journal

Nigerian journal of clinical practice
ISSN: 1119-3077
Titre abrégé: Niger J Clin Pract
Pays: India
ID NLM: 101150032

Informations de publication

Date de publication:
Aug 2021
Historique:
entrez: 16 8 2021
pubmed: 17 8 2021
medline: 18 8 2021
Statut: ppublish

Résumé

Increasing use of The objective of this study was to assess A total of 6500 patients followed-up in a single and tertiary center between January 2010 and September 2016 were retrospectively reviewed. Of 2850 patients assessed with Of 658 patients with Although this study demonstrated high probability of malignant disease with increased

Sections du résumé

BACKGROUND BACKGROUND
Increasing use of
AIMS OBJECTIVE
The objective of this study was to assess
METHODS METHODS
A total of 6500 patients followed-up in a single and tertiary center between January 2010 and September 2016 were retrospectively reviewed. Of 2850 patients assessed with
RESULTS RESULTS
Of 658 patients with
CONCLUSION CONCLUSIONS
Although this study demonstrated high probability of malignant disease with increased

Identifiants

pubmed: 34397034
pii: NigerJClinPract_2021_24_8_1217_323867
doi: 10.4103/njcp.njcp_637_18
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1217-1224

Déclaration de conflit d'intérêts

None

Auteurs

Ersin Ozaslan (E)

>Department of Medical Oncology, Kayseri Acibadem Hospital, Acıbadem University, Faculty of Medcine; Department of Medical Oncology, Kayseri Training and Research Hospital; Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey.

Melih Kiziltepe (M)

Department of Internal Medicine, Kayseri Training and Research Hospital, Kayseri, Turkey.

Ummuhan Addulrezzak (U)

Department of Nuclear Medicine, Erciyes University Faculty of Medicine, Kayseri, Turkey.

Mustafa Kula (M)

Department of Nuclear Medicine, Erciyes University Faculty of Medicine, Kayseri, Turkey.

Oktay Bozkurt (O)

Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey.

Engin Kut (E)

Department of Medical Oncology, Kayseri Training and Research Hospital, Kayseri, Turkey.

Ayse O Duran (AO)

Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey.

Mahmut Ucar (M)

Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey.

Teoman Sakalar (T)

Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey.

Ender Dogan (E)

Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey.

Ulas S Topaloglu (US)

Department of Internal Medicine, Kayseri Training and Research Hospital, Kayseri, Turkey.

Mevlude Inanc (M)

Department of Medical Oncology, Kayseri Training and Research Hospital; Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey.

Metin Ozkan (M)

Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH